Asymmetrex®, LLC

Asymmetrex® is a private, for-profit biotechnology company that specializes in technologies for stem cell medicine. Asymmetrex®'s founder, President and CEO is a leading authority on the unique properties of adult tissue stem cells. Asymmetrex holds a rich portfolio of intellectual property for technologies that address major barriers to success in regenerative medicine. These include patented methods for mass-producing adult tissue stem cells and their differentiated derivatives; counting adult tissue stem cells; engineering adult tissues stem cells; and evaluating effects of new drug candidates on adult tissue stem cells. Current products include renewable adult tissue stem cells strains for research applications and exclusive licensing of technologies for specific fields of use. In 2023, the company introduced the first-ever rapid-counting tissue stem cell calculators. The calculators are available free online at https://asymmetrex.com/stem-cell-counting-center. This first generation of free tissue stem cell calculators are applicable to commonly used human HSC-containing preparations and human adipose MSC-containing preparations. These and next-generation stem cell calculators will be used to develop the first commercial automated electronic tissue stem cell counters.